CHRISTINA ZACHAR: Open Payments
NPI 1265534804 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 42 payments from 9 companies in 2025. Trend: 2023 $858 · 2024 $864 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $201 |
| E.R. Squibb & Sons, L.L.C. | 8 | $162 |
| Vanda Pharmaceuticals Inc. | 6 | $126 |
| Alkermes, Inc. | 3 | $80 |
| ABBVIE INC. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, FANAPT, REXULTI, ABILIFY MAINTENA, ARISTADA, VRAYLAR, CAPLYTA, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
